Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
Neutralizing antibodies (nAbs) elicited against the receptor binding site (RBS) of the spike
protein of wild-type severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
protein of wild-type severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
[HTML][HTML] SARS-CoV-2 variant B. 1.1. 7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of
generating protective neutralizing antibodies. The recent emergence and rapid spread of …
generating protective neutralizing antibodies. The recent emergence and rapid spread of …
[PDF][PDF] COVID-19 weekly epidemiological update, edition 43, 8 June 2021
World Health Organization - 2021 - apps.who.int
Global case and death incidences continued to decrease with over 3 million new weekly
cases and over 73 000 new deaths, a 15% and an 8% decrease respectively, compared to …
cases and over 73 000 new deaths, a 15% and an 8% decrease respectively, compared to …
Pan-sarbecovirus neutralizing antibodies in BNT162b2-immunized SARS-CoV-1 survivors
Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of
concern pose a challenge to the effectiveness of current vaccines. A vaccine that could …
concern pose a challenge to the effectiveness of current vaccines. A vaccine that could …
Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant
Background Assessment of the safety and efficacy of vaccines against the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
M Kumari, RM Lu, MC Li, JL Huang, FF Hsu… - Journal of biomedical …, 2022 - Springer
The novel coronavirus disease (COVID-19) pandemic remains a global public health crisis,
presenting a broad range of challenges. To help address some of the main problems, the …
presenting a broad range of challenges. To help address some of the main problems, the …
BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting
Background As mass vaccination campaigns against coronavirus disease 2019 (Covid-19)
commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes …
commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes …
Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B. 1.1. 529
The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.
1.1. 529 (Omicron) variant and its resistance to neutralization by vaccinee and convalescent …
1.1. 529 (Omicron) variant and its resistance to neutralization by vaccinee and convalescent …
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
KKW To, S Sridhar, KHY Chiu, DLL Hung… - Emerging microbes & …, 2021 - Taylor & Francis
Without modern medical management and vaccines, the severity of the Coronavirus
Disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS) …
Disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS) …
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
The coronavirus disease-19 has left a permanent mark on the history of the human race.
Severe acute respiratory syndrome coronavirus-2 is a positive-sense single-stranded RNA …
Severe acute respiratory syndrome coronavirus-2 is a positive-sense single-stranded RNA …